These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 14034585)

  • 1. [The effect of digoxin on the size and functional capacity of the compensated infarct-damaged heart in the late phase of rehabilitation].
    KONIG K; REINDELL H; HOFFMANN G
    Dtsch Arch Klin Med; 1963; 208():654-85. PubMed ID: 14034585
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative long-term observations on the effect of kinesitherapy or digoxin treatment in patients with healed myocardial infarct].
    König K; Reindell H; Goldschmidt OF
    Med Welt; 1965 Oct; 44():2469-77. PubMed ID: 5879771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Functional capacity in patients after myocardial infarction dependent on treatment strategy in acute phase of disease].
    Lakusić N; Mahović D; Cerovec D; Baborski F; Majsec M
    Acta Med Croatica; 2005; 59(4):341-5. PubMed ID: 16334743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics.
    Baks T; van Geuns RJ; Biagini E; Wielopolski P; Mollet NR; Cademartiri F; van der Giessen WJ; Krestin GP; Serruys PW; Duncker DJ; de Feyter PJ
    J Am Coll Cardiol; 2006 Jan; 47(1):40-4. PubMed ID: 16386662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality.
    Palatsi I
    Acta Med Scand Suppl; 1976; 599():7-84. PubMed ID: 16981325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
    Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
    J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of myocardial function and perfusion by MRI two days and four months after acute myocardial infarction revascularised by primary angioplasty].
    Noël B; Morice MC; Kokis A; Garot J; Dumas P; Louvard Y; Tavolaro O; Lévy M; Lefèvre T
    Arch Mal Coeur Vaiss; 2007 Sep; 100(9):729-35. PubMed ID: 18032999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with the gap junction modifier rotigaptide (ZP123) reduces infarct size in rats with chronic myocardial infarction.
    Haugan K; Marcussen N; Kjølbye AL; Nielsen MS; Hennan JK; Petersen JS
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):236-42. PubMed ID: 16495761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial).
    Brodie BR; Webb J; Cox DA; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Dulas D; Rutherford B; Antoniucci D; Stuckey T; Krucoff M; Gibbons R; Lansky A; Na Y; Mehran R; Stone GW;
    Am J Cardiol; 2007 Jun; 99(12):1680-6. PubMed ID: 17560875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of periinfarct contrast-enhanced cardiac magnetic resonance imaging for the prediction of late postmyocardial infarction ventricular dysfunction.
    Rubenstein JC; Ortiz JT; Wu E; Kadish A; Passman R; Bonow RO; Goldberger JJ
    Am Heart J; 2008 Sep; 156(3):498-505. PubMed ID: 18760132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indicators of heart failure functional classes at the stage of sanatorium rehabilitation of patients with myocardial infarction].
    Selezneva LM
    Klin Med (Mosk); 2005; 83(9):57-8. PubMed ID: 16279043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
    Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
    J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function.
    Steen H; Giannitsis E; Futterer S; Merten C; Juenger C; Katus HA
    J Am Coll Cardiol; 2006 Dec; 48(11):2192-4. PubMed ID: 17161244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
    Britten MB; Abolmaali ND; Assmus B; Lehmann R; Honold J; Schmitt J; Vogl TJ; Martin H; Schächinger V; Dimmeler S; Zeiher AM
    Circulation; 2003 Nov; 108(18):2212-8. PubMed ID: 14557356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of infarct size by single measurements of creatine kinase levels in patients with a first myocardial infarction.
    Di Chiara A; Plewka M; Werren M; Badano LP; Fresco C; Fioretti PM
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):340-6. PubMed ID: 16645412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction.
    Nijveldt R; Beek AM; Hofman MB; Umans VA; Algra PR; Spreeuwenberg MD; Visser CA; van Rossum AC
    J Cardiovasc Magn Reson; 2007; 9(5):765-70. PubMed ID: 17891613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home-based versus hospital-based rehabilitation after myocardial infarction: A randomized trial with preference arms--Cornwall Heart Attack Rehabilitation Management Study (CHARMS).
    Dalal HM; Evans PH; Campbell JL; Taylor RS; Watt A; Read KL; Mourant AJ; Wingham J; Thompson DR; Pereira Gray DJ
    Int J Cardiol; 2007 Jul; 119(2):202-11. PubMed ID: 17196274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging.
    Kelle S; Roes SD; Klein C; Kokocinski T; de Roos A; Fleck E; Bax JJ; Nagel E
    J Am Coll Cardiol; 2009 Nov; 54(19):1770-7. PubMed ID: 19874990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma brain natriuretic peptide correlates with infarct size but not with subsequent remodeling in the rat heart.
    Maczewski M; Mackiewicz U
    Cardiovasc Pathol; 2007; 16(2):79-84. PubMed ID: 17317540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.